Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Core Genes Shared by Endometrial Cancer and Ovarian Cancer Using an Integrated Approach. | Cell Mol Biol (Noisy-le-grand) | 2022 | 36905262 | PubTator, text mining | PubMed |
| HMMR potential as a diagnostic and prognostic biomarker of cancer-speculation based on a pan-cancer analysis. | Front Surg | 2022 | 36704516 | PubTator, text mining | PubMed |
| Prognostic significance of CKAP2L expression in patients with clear cell renal cell carcinoma. | Front Genet | 2022 | 36699449 | PubTator, text mining | PubMed |
| Identifying gene expression-based biomarkers in online learning environments. | Bioinform Adv | 2022 | 36699355 | PubTator, text mining | PubMed |
| High expression of KNL1 in prostate adenocarcinoma is associated with poor prognosis and immune infiltration. | Front Genet | 2022 | 36685823 | PubTator, text mining | PubMed |
| Using publicly available datasets to identify population-based transcriptomic landscape contributing to the aggressiveness of breast cancer in young women. | Front Genet | 2022 | 36685821 | PubTator, text mining | PubMed |
| RSK1 and RSK2 serine/threonine kinases regulate different transcription programs in cancer. | Front Cell Dev Biol | 2022 | 36684450 | PubTator, text mining | PubMed |
| Lipedema Research-Quo Vadis? | J Pers Med | 2022 | 36675759 | PubTator, text mining | PubMed |
| Overview of triple negative breast cancer prognostic signatures in the context of data science-driven clinico-genomics research. | Ann Transl Med | 2022 | 36660729 | PubTator, text mining | PubMed |
| Pan-cancer analysis of DEPDC1 as a candidate prognostic biomarker and associated with immune infiltration. | Ann Transl Med | 2022 | 36660720 | PubTator, text mining | PubMed |
| Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer. | Cancers (Basel) | 2022 | 36612226 | PubTator, text mining | PubMed |
| The Mechanism of Quercetin in the Treatment of Lung Squamous Cell Carcinoma Based on a Protein-Protein Interaction Network. | Evid Based Complement Alternat Med | 2022 | 36605099 | PubTator, text mining | PubMed |
| The Novel Action of miR-193b-3p/CDK1 Signaling in HCC Proliferation and Migration: A Study Based on Bioinformatic Analysis and Experimental Investigation. | Int J Genomics | 2022 | 36600989 | PubTator, text mining | PubMed |
| Screening of Key Prognosis Genes of Lung Adenocarcinoma Based on Expression Analysis on TCGA Database. | J Oncol | 2022 | 36600965 | PubTator, text mining | PubMed |
| Clinical value and potential mechanisms of BUB1B up-regulation in nasopharyngeal carcinoma. | BMC Med Genomics | 2022 | 36577966 | PubTator, text mining | PubMed |
| Comparative RNA-Sequencing Analysis Reveals High Complexity and Heterogeneity of Transcriptomic and Immune Profiles in Hepatocellular Carcinoma Tumors of Viral (HBV, HCV) and Non-Viral Etiology. | Medicina (Kaunas) | 2022 | 36557005 | PubTator, text mining | PubMed |
| Significance of Identifying Key Genes Involved in HBV-Related Hepatocellular Carcinoma for Primary Care Surveillance of Patients with Cirrhosis. | Genes (Basel) | 2022 | 36553600 | PubTator, text mining | PubMed |
| Bioinformatics Prediction and Machine Learning on Gene Expression Data Identifies Novel Gene Candidates in Gastric Cancer. | Genes (Basel) | 2022 | 36553500 | PubTator, text mining | PubMed |
| Lipedema: Insights into Morphology, Pathophysiology, and Challenges. | Biomedicines | 2022 | 36551837 | PubTator, text mining | PubMed |
| Systems Biology Analysis of Temporal Dynamics That Govern Endothelial Response to Cyclic Stretch. | Biomolecules | 2022 | 36551265 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=25